These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23623811)

  • 1. [Comment on the study «recommendations on the use of 5-amino-levulinic acid in surgery of malignant gliomas. Consensus document», by Gil-Salú et al].
    Brel M
    Neurocirugia (Astur); 2013; 24(4):170-1. PubMed ID: 23623811
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations on the use of 5-amino-levulinic acid in surgery of malignant gliomas. Consensus document. The Neuro-oncology Working Group of the Spanish Neurosurgical Society (SENEC)].
    Gil-Salú JL; Arraez MÁ; Barcia JA; Piquer J; Rodríguez de Lope A; Villalba Martínez G;
    Neurocirugia (Astur); 2013; 24(4):163-9. PubMed ID: 23602279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-guided surgery for high-grade gliomas.
    Lakomkin N; Hadjipanayis CG
    J Surg Oncol; 2018 Aug; 118(2):356-361. PubMed ID: 30125355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?
    Díez Valle R; Tejada Solis S
    CNS Oncol; 2015; 4(4):265-72. PubMed ID: 26118538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-ALA and FDA approval for glioma surgery.
    Hadjipanayis CG; Stummer W
    J Neurooncol; 2019 Feb; 141(3):479-486. PubMed ID: 30644008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note.
    Morshed RA; Han SJ; Lau D; Berger MS
    J Neurosurg; 2018 May; 128(5):1448-1453. PubMed ID: 28665248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence-Guided Surgery for High-Grade Gliomas: State of the Art and New Perspectives.
    Palmieri G; Cofano F; Salvati LF; Monticelli M; Zeppa P; Perna GD; Melcarne A; Altieri R; La Rocca G; Sabatino G; Barbagallo GM; Tartara F; Zenga F; Garbossa D
    Technol Cancer Res Treat; 2021; 20():15330338211021605. PubMed ID: 34212784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
    Chohan MO; Berger MS
    J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of 5-aminolevulinic acid in resection of pediatric brain tumors: a critical review.
    Zhang C; Boop FA; Ruge J
    J Neurooncol; 2019 Feb; 141(3):567-573. PubMed ID: 30443833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic-assisted 5-aminolevulinic acid imaging.
    Schwartz TH
    World Neurosurg; 2014; 82(1-2):e117-8. PubMed ID: 23920307
    [No Abstract]   [Full Text] [Related]  

  • 11. State of the art of fluorescence guided techniques in neurosurgery.
    La Rocca G; Della Pepa GM; Menna G; Altieri R; Ius T; Rapisarda A; Olivi A; Sabatino G
    J Neurosurg Sci; 2019 Dec; 63(6):619-624. PubMed ID: 31961115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 2: theoretical, biochemical and practical aspects.
    Colditz MJ; Leyen Kv; Jeffree RL
    J Clin Neurosci; 2012 Dec; 19(12):1611-6. PubMed ID: 23059058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence image-guided neurosurgery.
    Kaneko S; Eljamel MS
    Future Oncol; 2017 Nov; 13(26):2341-2348. PubMed ID: 29121788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review.
    Ferraro N; Barbarite E; Albert TR; Berchmans E; Shah AH; Bregy A; Ivan ME; Brown T; Komotar RJ
    Neurosurg Rev; 2016 Oct; 39(4):545-55. PubMed ID: 26815631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
    Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
    World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established and emerging uses of 5-ALA in the brain: an overview.
    Díez Valle R; Hadjipanayis CG; Stummer W
    J Neurooncol; 2019 Feb; 141(3):487-494. PubMed ID: 30607705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
    Rapp M; Kamp M; Steiger HJ; Sabel M
    World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of autofluorescence and quantitative protoporphyrin IX biomarkers for optical spectroscopy-guided glioma surgery.
    Black D; Kaneko S; Walke A; König S; Stummer W; Suero Molina E
    Sci Rep; 2021 Oct; 11(1):20009. PubMed ID: 34625597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
    Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
    J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.